当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Molecular Cancer Therapeutics杂志
Molecular Cancer Therapeutics
基本信息
期刊名称 Molecular Cancer Therapeutics
MOL CANCER THER
期刊ISSN 1535-7163
期刊官方网站 http://mct.aacrjournals.org/
是否OA No
出版商 American Association for Cancer Research Inc.
出版周期 Monthly
文章处理费 登录后查看
始发年份 2001
年文章数 116
影响因子 5.3(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学2区 ONCOLOGY 肿瘤学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 11.2 2.270 1.016
Medicine
Oncology
48/404 88%
Biochemistry, Genetics and Molecular Biology
Cancer Research
41/230 82%
补充信息
自引率 2.60%
H-index 157
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1535-7163%5BISSN%5D
投稿指南
期刊投稿网址 http://mct.msubmit.net/cgi-bin/main.plex
收稿范围
Molecular Cancer Therapeutics publishes translational research studies focused on the discovery and preclinical development of therapeutic agents for oncology. To reflect the evolving field of therapeutics, the journal’s interest extends to all selective drugs including small molecule inhibitors, antibody-drug conjugates, antibody cytokine fusions, bispecific antibodies, cell therapies, gene therapies, radio-immunotherapeutics, vaccines, viral therapies, and other experimental approaches in oncology.

Specific areas of interest are the disclosure of translational investigations of novel drug therapies, preclinical studies of approved therapeutics (including their combination with radiation therapy), mechanisms of action, mitigation of resistance, biomarkers of response, novel models and technology, and applications of big data in drug discovery.
收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息

                                
我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug